IRS1 and Insulin resistance: Evodiamine improved glucose tolerance and reduced insulin resistance in obese/diabetic mice, which was possibly related to inhibition of mammalian target of rapamycin (mTOR)- S6 protein kinase (S6K) signaling and insulin receptor substrate 1 (IRS1) serine phosphorylation in adipocytes [194].